fda glp-1 safety alert october 2025 The says it plans to act against non-approved compounded products being mass-marketed as alternatives to approved drugs. That tells you how wild the obesity-drug market has become. The agency's concern Pharmacovigilance analysis of neurological adverse

But it could help clinicians optimize therapy for patients who have trouble affording the drugs or who struggle with gastrointestinal issues or other side effects, she says

This heterogeneity is clinically relevant for peri-implant disease because the oral environment supplies a complex conditioning layer (salivary proteins, blood components during surgery) that can either amplify or dampen a pure wettability effect

for example, states like Oregon and Colorado have created legal pathways for the therapeutic or supervised use of psilocybin, creating a complex tension between state and federal laws [131]

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

doi: 10.1056/NEJMoa2022190